FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

Ex-FDA Lawyer Temkin Joins Paul Hastings

Former FDA associate chief counsel and CDER policy advisor Eva A. Temkin joins Paul Hastings as chair of the firms FDA practice.

latest-news-card-1
Medical Devices

Vyaire Recalls Airlife Resuscitator

Vyaire Medical recalls its AirLife Adult Manual Resuscitator and oxygen reservoir bag due to out-of-specification components used in manufacturing.

latest-news-card-1
Human Drugs

Milestone Pharma Refiling Etrpamil NDA

After receiving a 12/2023 FDA refuse-to-file letter, Milestone Pharmaceuticals now says it will resubmit the NDA in the second quarter for etripamil n...

latest-news-card-1
Federal Register

Animal Drug Regs Amended to Reflect Approvals

Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions animal drug applications approved during the fo...

latest-news-card-1
Human Drugs

Boehringer Reports Gains on Liver Disease Candidate

Boehringer Ingelheim reports data from its Phase 2 survodutide study showing that up to 83.0% of adults treated with the drug achieved a statistically...

latest-news-card-1
Biologics

After 2 Earlier Denials, Humira Biosimilar OKd

FDA approves Alvotech and Teva Pharmaceuticals Simlandi (adalimumab-ryvk) injection, an interchangeable biosimilar to AbbVies Humira.

latest-news-card-1
Federal Register

Rybrevants Regulatory Review Period Determined

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Janssen Biotechs Rybrevant (amivantamab-vmjw).

latest-news-card-1
Human Drugs

New App for Reporting Drug Amounts Produced

FDA creates a new CARES Act Amount Information Reporting application for drug establishments to use when submitting (xxx insert, delete xxx) annual re...

latest-news-card-1
Human Drugs

FDA Denies Appeal; Pepaxto to be Withdrawn

FDA rejects an Oncopeptides appeal seeking to stop a CBER request for the company to voluntarily withdraw its accelerated-approved multiple myeloma dr...

latest-news-card-1
Human Drugs

NY Attorney General Urges FDA Action on Singulair

New York attorney general Letitia James urges FDA to take further safety actions to address the dangers of Mercks Singilair (montelukast) and generics...